Records 1-30 (of 32 Record(s))

Filtered By: Select to fine-tune your search Country Journal Gene Publication Type

Next

Query Trace: Prostate Cancer[original query]

---

• BRCA testing delay during the COVID-19 pandemic: How to act?
  Minucci Angelo, et al. Molecular biology reports 2020 12 0.
  
• Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway.
  Afshari Afsoon, et al. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2020 12 0. 104669
  
• ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease.
  Singh HariOm, et al. Microbial pathogenesis 2020 12 0. 104621
  
• Sex differences in COVID-19: the role of androgens in disease severity and progression.
  Mohamed Mohamed S, et al. Endocrine 2020 11 0.
  
• Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study.
  Zhou Jingqi, et al. Brain, behavior, and immunity 2020 10 0.
  
• Classical Drug Digitoxin Inhibits Influenza Cytokine Storm, With Implications for Covid-19 Therapy.
  Pollard Bette S, et al. In vivo (Athens, Greece) 0 0 0. (6) 3723-3730
  
• Prostate cancer: a risk factor for COVID-19 in males?: A protocol for systematic review and meta analysis.
  Mou Ruiyu, et al. Medicine 2020 10 0. (43) e22591
  
• Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method.
  Lucchetta Marta, et al. Scientific reports 2020 0 0. (1) 17628
  
• Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19
  Q Deng et al, BIORXIV, October 16, 2020
  
• Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists.
  Rosenzweig Barak, et al. Urologic oncology 2020 10 0.
  
• Neprilysin expression and functions in development, ageing and disease.
  Nalivaeva N N, et al. Mechanisms of ageing and development 2020 9 0. 111363
  
• The management of patients with metastatic prostate cancer during the COVID-19 pandemic.
  Assi Tarek, et al. Future oncology (London, England) 2020 7 0. (20) 1455-1461
  
• Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic.
  Wallis Christopher J D, et al. European urology 2020 7 0. (1) 29-42
  
• Clinical and Surgical Assistance in Prostate Cancer during the COVID-19 Pandemic: Implementation of assistance protocols.
  Sanchez Lara Rodriguez, et al. International braz j urol : official journal of the Brazilian Society of Urology 2020 0 0. (suppl.1) 50-61
  
• Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy.
  Di Lorenzo Giuseppe, et al. Oncology 2020 6 0. 1-5
  
• Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic.
  Carril-Ajuria Lucil, et al. Oncology (Williston Park, N.Y.) 2020 0 0. (8) 317-319
  
• COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.
  Mjaess G, et al. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 2020 5 0.
  
• Management of prostate cancer patients during COVID-19 pandemic.
  Obek Can, et al. Prostate cancer and prostatic diseases 2020 0 0. (3) 398-406
  
• Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic.
  Diamand Romain, et al. World journal of urology 2020 8 0.
  
• Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer.
  Cattrini Carlo, et al. Cancers 2020 8 0. (8)
  
• Androgen Deprivation Therapy in Men With Prostate Cancer Does Not Affect Risk of Infection With SARS-CoV-2.
  Klein Eric A, et al. The Journal of urology 2020 9 0. 101097JU0000000000001338
  
• Gene of the month: TMPRSS2 (transmembrane serine protease 2).
  Thunders Michelle, et al. Journal of clinical pathology 2020 9 0.
  
• Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA.
  Barata Pedro, et al. Journal for immunotherapy of cancer 2020 0 0. (2)
  
• Crosstalk between COVID-19 and prostate cancer.
  Bahmad Hisham F, et al. Prostate cancer and prostatic diseases 2020 7 0.
  
• Structure of human steroid 5α-reductase 2 with anti-androgen drug finasteride.
  Xiao Qingpin, et al. Research square 2020 7 0.
  
• Structural variability, expression profile and pharmacogenetics properties of TMPRSS2 gene as a potential target for COVID-19 therapy
  A Zarubin et al, BIORXIV, June 20, 2020
  
• COVID-19 and androgen targeted therapy for prostate cancer patients.
  Bhowmick Neil A, et al. Endocrine-related cancer 2020 6 0.
  
• Androgen sensitivity gateway to COVID-19 disease severity.
  Wambier Carlos Gustavo, et al. Drug development research 2020 5 0.
  
• Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532).
  Montopoli M, et al. Annals of oncology : official journal of the European Society for Medical Oncology 2020 5 0.
  
• Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?
  McCoy John, et al. Journal of cosmetic dermatology 2020 4 0.
  

Next

---